Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Operating expenses:
Research and development	$ 5,782,094	$ 1,205,599	$ 6,245,946	$ 1,952,481
General and administrative	1,182,872	918,139	2,512,707	2,141,152
Total operating expenses	6,964,966	2,123,738	8,758,653	4,093,633
Loss from operations	(6,964,966)	(2,123,738)	(8,758,653)	(4,093,633)
Other income (expense):
Interest income	485	9,642	3,863	14,271
Interest expense	(2,914)		(2,914)
Total other income (expense)	(2,429)	9,642	949	14,271
Net loss	$ (6,967,395)	$ (2,114,096)	$ (8,757,704)	$ (4,079,362)
Net loss per share of common stock, basic and diluted	$ (0.28)	$ (0.09)	$ (0.35)	$ (0.20)
Weighted-average shares used to compute basic and diluted net loss per share	24,987,975	23,258,567	24,713,928	20,371,442